Pediatric Blood & Cancer

Papers
(The H4-Index of Pediatric Blood & Cancer is 23. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
89
Comparing Absolute Neutrophil Counts of Children With Sickle Cell Disease With and Without the Duffy Null Phenotype50
Brochure intervention to manage bothersome taste changes in pediatric patients receiving cancer therapy46
Palliative care and suicidality: Complicated conversations at two ends of the spectrum44
42
Response assessment by positron emission tomography‐computed tomography as compared with contrast‐enhanced computed tomography in childhood Hodgkin lymphoma can reduce the need for radiotherapy in low41
Fatal brainstem injury following proton radiation in a patient with medulloblastoma and a germline variant in RNF21341
Urgent Chemotherapy for Swift Symptom Relief in Patients With Medulloblastoma41
Efficacy of dual‐task training on stability and function in children with ataxia after medulloblastoma resection: A randomized controlled trial36
Automating the treatment planning process for 3D‐conformal pediatric craniospinal irradiation therapy35
Prevalence of Duffy null and its impact on hydroxyurea in young children with sickle cell disease in the United States32
Mini‐hyper CVD + CRIB (condensed rituximab, inotuzumab ozogamicin, and blinatumomab) for refractory pediatric B‐acute lymphoblastic leukemia27
Feasibility of indocyanine green‐guided localization of pulmonary nodules in children with solid tumors27
Refractory thrombocytopenia and myelofibrosis in a novel KDSR mutation: Case report and literature review27
Quality of life and late therapy effects in pediatric non‐Hodgkin lymphoma survivors: Insights from a single‐institution study26
Prognostic factors of sepsis in children with acute leukemia admitted to the pediatric intensive care unit26
Pediatric erythroblastic transformation of JAK2‐mutated prefibrotic primary myelofibrosis with concurrent PHF6 mutations26
Neonatal giant axillary hemangioma with subclavian arteriovenous fistula and heart failure23
Psychosexual functioning in cancer survivorship: What the pediatric oncologist needs to know23
Children's Oncology Group 2023 blueprint for research: Cancer care delivery research23
The role of neoadjuvant chemotherapy in the management of metastatic central nervous system germinoma: A meta‐analysis23
ALK inhibition as a salvage therapy for a relapsed unclassifiable sarcomatous CNS tumor with EML4/ALK fusion in an infant23
Image‐Guided Biopsy for the Diagnosis and Molecular Profiling of Hepatoblastoma23
0.14166498184204